Towards Quantum Advantage by 2026: IBM’s Vision for Life Sciences
June 12, 2025 @ 10:00 – 12:00 CEST
Join us for a special guest talk with Dr. Gopal Karemore, as he outlines how quantum computing is unlocking new possibilities in biomedical research and reshaping the future of healthcare innovation.
With a background in data science and nearly a decade at Novo Nordisk, Gopal now leads IBM Quantum’s global strategy for applying quantum technologies to challenges in drug discovery, biomolecular simulation, and precision medicine to help enterprise clients. His work includes advancing methods like Sample-Based Quantum Diagonalization (SBQD) and contributing in collaborations with organizations such as Moderna and Cleveland Clinic. In this session, Gopal will:
- Introduce IBM’s roadmap to achieving quantum advantage by 2026
- Discuss how quantum technologies intersect with key challenges in healthcare and life sciences
- Share real-world use cases from IBM’s work in quantum simulation, quantum optimization, quantum machine learning and collaborative biomedical ecosystems
- Explore how researchers, scientists, and Nordic startups can engage with IBM — whether through programs like the Quantum Accelerator or other pathways — to gain access to quantum technologies already available today.
- This talk is ideal for scientists, clinicians, data specialists, and innovators interested in the next frontier of life science computation — and how Sweden’s research community can help shape it.
Place: SciLife Lab, Tomtebodavägen 23, Solna. Conference room “Air&Fire”.
Agenda:
10.15 – 10:30 – Doors open & welcome
10:30 – 11:30 – Presentation by Gopal Karemore followed by Q&A
11:30 –12:00 – Lunch & networking mingle
About the Speaker:
Dr. Gopal Karemore is the Global Quantum Lead for Healthcare and Life Sciences at IBM Research, based at the T.J. Watson Research Centre in New York. He leads efforts to drive the adoption of quantum computing in life sciences and healthcare, working with IBM teams and external partners to deliver high-impact solutions. With over 14 years of experience in pharmaceutical research, Dr. Karemore brings deep expertise in data science, machine learning, and quantum computing. He holds a Ph.D. in Computer Science from the University of Copenhagen and has contributed to shaping innovation and business development across pharmaceutical R&D. Prior to joining IBM, he held research and leadership roles at Novo Nordisk, Spanish National Centre for Cardiovascular Research, Danish Stem Cell Centre, Centre for Protein Research, Fraunhofer Institute, and Penn Medicine.
Google Calendar 